Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
American Pharma SummitAmerican Pharma Summit
Not Confirmed
Not Confirmed
18-19 November, 2024
Pharma Manufacturing 2...Pharma Manufacturing 2024
Not Confirmed
Not Confirmed
18-19 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
American Pharma SummitAmerican Pharma Summit
Industry Trade Show
Not Confirmed
18-19 November, 2024
Pharma Manufacturing 2...Pharma Manufacturing 2024
Industry Trade Show
Not Confirmed
18-19 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
02 Aug 2022
// Kyle LaHucik ENDPTS
https://endpts.com/beigene-co-founder-and-ex-viela-bio-bd-leader-snag-200m-for-age-related-biotech-with-arch-jumping-in/
19 May 2022
// EMA
https://www.ema.europa.eu/en/documents/overview/uplizna-epar-medicine-overview_en.pdf
01 Oct 2021
// Kevin Dunleavy FIERCEPHARMA
https://www.fiercepharma.com/pharma/insider-trading-2-pharma-m-a-deals-made-former-goldman-sachs-compliance-officer-more-than
26 Feb 2021
// BIOSPACE
https://www.biospace.com/article/releases/viela-bio-announces-additional-positive-results-with-uplizna-inebilizumab-cdon-in-patients-with-neuromyelitis-optica-spectrum-disorder-at-the-actrims-2021-forum/
25 Feb 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/fr/news-release/2021/02/25/2182496/0/en/Viela-Bio-Announces-Additional-Positive-Results-with-UPLIZNA-inebilizumab-cdon-in-Patients-with-Neuromyelitis-Optica-Spectrum-Disorder-at-the-ACTRIMS-2021-Forum.html
03 Feb 2021
// John Lauerman BLOOMBERG
https://www.bloomberg.com/news/articles/2021-02-01/horizon-therapeutics-to-purchase-viela-bio-for-3-1-billion
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?